Pharma Marketing News
Subscribe Glossary
Pharma Marketing Blog Discussion Forums Audio Podcasts Conference Calendar Reader Surveys

PMN Home | Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
Competitive Landscape Seminar: Healthcare Reform
Competitive Landscape Seminar: Healthcare Reform | May 6
Share |

Featured Survey:
Pharma Mobile Health App Best Practices
Pharma Mobile Health App Best Practices Survey
Pharma Mobile Health App Best Practices Survey

As the pharmaceutical industry begins to develop health apps it must contend with a number of issues such as regulation by the FDA, privacy and HIPAA issues, consumer trust, etc. This survey seeks your opinion on an array of such issues. Please take 5 minutes to respond to a few questions. Take the Survey Now. Afterward you will be able to view the de-identified results to date.

Vol. 13, Issue No. 4: April 2014 - EXECUTIVE SUMMARY

Pharma Finds Little to Like in Recent FDA Social Media Guidance
Delete, Limit, & Clarify Says Industry

Little to Like The comments are in! As usual, the pharma industry waited until the last minute to submit comments to FDA Docket 2013-N-1430 regarding "Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Sub-missions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics."

This article provides highlights from submissions by Novartis, Shire, the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country's leading pharmaceutical research and biotechnology companies, the Biotechnology Industry Organization (BIO), Klick Health, the Social Media Compliance Council (SMCC), the Coalition for Healthcare Communication (CHC), and the Digital Health Coalition (DHC), and other interested parties.

Topics include (partial list):
  • Links to All Comments
  • Figure: Focus of Comments Submitted
  • What Constitutes "Influence?"
  • FDA vs. "Journalism Ethics"
  • Scope of Control Over 3rd Party Sites
  • Off-Label Adjacency
  • PhRMA Questions Legality
  • Impact on Earned Media Coverage
  • Burdensome Paperwork!
  • User-Generated Content
  • To Moderate or Not Moderate?
  • Employee-Generated Content
  • A Social Media "Laboratory"
  • Possible Real-World Scenarios
  • FDA Intern: The Quest for Social Media Guidelines
  • What About Pre-Approval Social Media?
The full text of this article is available to subscribers. Subscription is free.

Pharma Marketing News Email Addr:  

The Sorry State of Pharma Mobile Health Apps
Lack of Security, Continuity and Platform Standardization, Distribution Challenges, Poor ROI

Pharma Mobile App Black Hole At a recent eyeforpharma Philadelphia 2014 Summit, Carolyn Gauntlett, Senior Innovation Consultant with IMS Health, gave an interesting presentation titled "How to Make Sure You're Getting the Most Out of Your mHealth App Development."

This articles summarizes some major points made in that presentation as well as data from the report "Patient Apps for Improved Healthcare: From Novelty to Mainstream" published by IMS Institute for Healthcare Informatics.

Topics include (partial list):
  • Some Docs Prescribe More Apps Than Pills
  • So, Why Hasn't Mobile Health "Exploded?"
  • More Apps, Less Meds?
  • Few mHealth Apps Are Worthy
  • Figure: Health App Functionality Score Distribution
  • The Pharma App Black Hole
  • Poor ROI
The full text of this article is available to subscribers. Subscription is free.

Pharma Marketing News Email Addr:  

Vol 13, #4 Contents





Search All Pharma Marketing News Pages

Messages from Our Sponsors

Pharma Marketing News Email Addr:  

Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Discussion Forums | Podcasts | Blog
Daily News Briefs | Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. VirSci Corporation. All rights reserved.